Company profilePharmaceutical#1001 of 1,318 in Pakistan✓ No DRAP alerts

ADFA SAN PHARMACEUTICALS.

Pharmaceutical company · 4 brands · 3 molecules

4 registered products 3 pharmaceutical brands 3 distinct molecules 0 DRAP alerts

Company overview

4
registered products
3
pharmaceutical brands
3
distinct molecules
0
therapeutic classes
0
DRAP alerts

ADFA SAN PHARMACEUTICALS. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 4 product registrations across 3 distinct molecules. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Top molecules by brand count

Tenoxicam1 brand
Pefloxacin1 brand
Famotidine1 brand

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

FYNK PHARMACEUTICALS2 shared molecules
PEARL PHARMACEUTICALS1 shared molecules
A.J. & COMPANY.1 shared molecules
Wnsfeild Pharmaceuticals1 shared molecules
Roche Pakistan Limited.1 shared molecules
GRAY`S PHARMACEUTICALS1 shared molecules
TAGMA PHARMA (PVT) LTD.1 shared molecules

Get the full profile for ADFA

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.